Healthy Skepticism Library item: 6573

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Mansfield P.
Re: the promotion of Orudis (ketoprofen)
1995 Feb;

Abstract:

Rhone-Poulenc Rorer claims that Orudis SR has high gastrointestinal tolerance. This claim is not supported by the refences that are cited in the advertisements nor by comparisons with other nonsteroidal anti-inflammatory agents.

Keywords:
*analysis/Australia/developed countries/Orudis SR/ketoprofen/safety & risk information/Rhone-Poulenc/NSAID/ nonsteroidal anti-inflammatory drugs/MaLAM/Medical Lobby for Appropriate Marketing/EVALUATION OF PROMOTION: DRUG SAFETY/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPED COUNTRIES